Validation of the Kidney Failure Risk Equation in a Large Portuguese Cohort: Analysis of Diabetic and Heart Failure Subgroups

Authors

DOI:

https://doi.org/10.71749/pkj.140

Keywords:

Diabetic Nephropathies, Heart Failure, Kidney Failure, Chronic, Renal Insufficiency, Chronic, Models, Theoretical, Risk Assessment

Abstract

Introduction: The Kidney Failure Risk Equation (KFRE) is a validated tool for predicting kidney replacement therapy (KRT) initiation. However, its performance in Portuguese populations and specific subgroups, such as those with diabetic kidney disease (DKD) and heart failure (HF), requires further validation.
We aimed to validate the 4-variable KFRE at 2 and 5 years in a Portuguese chronic kidney disease (CKD) cohort and assess its performance in DKD and HF subgroups.

Methods: Retrospective cohort study of 1741 consultations from 1728 patients (CKD stages 3–5) followed between 2012 and 2019. Discriminatory power was evaluated using the area under the receiver operating characteristic curve (AuROC).

Results: The cohort had a median age of 73.9 years (IQR 13.9) and a median eGFR of 34 mL/min/1.73m². During a median follow-up of 25.9 months in the 2-year cohort (N=1741) and 38.2 months in the 5-year cohort (N=806), 167 (9.6%) and 242 (30.0%) patients initiated KRT, respectively, and 331 (19.0%) died. The KFRE showed good discrimination, with an AuROC of 0.914 (95% CI: 0.884–0.944) at 2 years and 0.914 (95% CI: 0.888–0.940) at 5 years. In the DKD subgroup, discrimination was higher at 5 years (AuROC 0.942) than at 2 years (0.918). In the HF subgroup, discrimination remained accurate, although slightly lower at 2 years (AuROC 0.873) than at 5 years (0.906). Discrimination remained high after excluding stage 5 CKD. Limitations include the retrospective design and high competing mortality.

Conclusion: The 4-variable KFRE showed good discrimination for predicting KRT in Portuguese CKD patients over both 2- and 5-year time horizons. Its adequate discrimination in DKD and HF subgroups supports its clinical utility for risk stratification and transition of care.

Downloads

Download data is not yet available.

References

Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodriguez-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16:269-88. doi:10.1038/s41581-019-0248-y

Santos-Araújo C, Mendonça L, Carvalho DS, Bernardo F, Pardal M, Couceiro J, et al. Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population. Clin Kidney J. 2023;16:111-24. doi:10.1093/ckj/sfac206

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12:7-11. doi: 10.1016/j.kisu.2021.11.003.

Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure. JAMA. 2011;305:1553-9. doi:10.1001/jama.2011.451

Kwek JL, Pang HQJ, Li H, Lim WWL, Choo JCJ, Choong HL, et al. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort. Singapore Med J. 2022;63:313-8. doi:10.11622/smedj.2020170 (doi:10.11622/smedj.2020170)

Bravo-Zúñiga J, Chávez-Gómez R, Soto-Becerra P. Multi-centre external validation of the prognostic model kidney failure risk equation in patients with CKD stages 3 and 4 in Peru: a retrospective cohort study. BMJ Open. 2024;14. 2024;14:e076217. doi:10.1136/bmjopen-2023-076217

Naranjo FS, Sang Y, Ballew SH, Stempniewicz N, Dunning SC, Levey AS, et al. Estimating Kidney Failure Risk Using Electronic Medical Records. Kidney360. 2021;2:415-24. doi:10.34067/KID.0005592020

Ramspek CL, Evans M, Wanner C, Drechsler C, Chesnaye NC, Szymczak M, et al. Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD. J Am Soc Nephrol. 2021;32:1174-86. doi:10.1681/ASN.2020071077

Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure. JAMA. 2016;315:164-74. doi:10.1001/jama.2015.18202

Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. The kidney failure risk equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study. PLoS Med. 2019;16:e1002955. doi:10.1371/journal.pmed.1002955

Escamilla-Cabrera B, Montomoli M, Kislikova M, de la Espada V, Olarte-García A, García-Prieto AM, et al. Validation multicéntrica de la fórmula Kidney Failure Risk Equation (KFRE) en pacientes españoles con enfermedad renal crónica avanzada. Nefrología. 2025;45:388-96. doi:10.1016/j.nefro.2025.02.004

Lennartz CS, Pickering JW, Seiler-Mußler S, Bauer L, Untersteller K, Emrich IE, et al. External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters. Clin J Am Soc Nephrol. 2016;11:609-15. doi:10.2215/CJN.08110715.

Irish GL, Cuthbertson L, Kitsos A, Saunder T, Clayton PA, Jose MD. The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort. Nephrology. 2023;28:328-35. doi:10.1111/nep.14260

Wang Y, Nguyen FN, Allen JC, Lew JQL, Tan NC, Jafar TH. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. BMC Nephrol. 2019;20:451. doi:10.1186/s12882-019-1643-0

Maher F, Teece L, Major RW, Bradbury N, Medcalf JF, Brunskill NJ, et al. Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study. Diagn Progn Res. 2023;7:22. doi:10.1186/s41512-023-00157-x

Whitlock RH, Chartier M, Komenda P, Hingwala J, Rigatto C, Walld R, et al. Validation of the kidney failure risk equation in Manitoba. Can J Kidney Health Dis. 2017;4:2054358117705372. doi:10.1177/2054358117705372

Sullivan MK, Jani BD, Rutherford E, Welsh P, McConnachie A, Major RW, et al. Potential impact of NICE guidelines on referrals from primary care to nephrology: A primary care database and prospective research study. Br J Gen Pract. 2023;73:E141–7. doi:10.3399/BJGP.2022.0145

da Silva BM, Charreu J, Duarte I, Outerelo C, Gameiro J. Validation of the kidney failure risk equation in a Portuguese cohort. Nefrologia. 2023;43:467–73. doi:10.1016/j.nefroe.2022.03.007

Rozi NR, Selvaraj CS, Tan JK, Lim ZF, Nordin NW, Mazhar NH, et al. Kidney failure risk equation (KFRE), A risk-based triage for nephrology referrals: A mixed-methods study at pre-implementation phase among healthcare providers. Prim Care Diabetes. 2025;19:636–45. doi:10.1016/j.pcd.2025.08.001

Goubar A, Mangelis A, Thomas S, Fountoulakis N, Collins J, Ayis S, et al. Investigation of end-stage kidney disease risk prediction in an ethnically diverse cohort of people with type 2 diabetes: use of kidney failure risk equation. BMJ Open Diabetes Res Care. 2024;12:e004282. doi:10.1136/bmjdrc-2024-004282

Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105:5117–514. doi:10.1016/j.kint.2023.10.018

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-12. doi:10.7326/0003-4819-150-9-200905050-00006. Erratum in: Ann Intern Med. 2011;155:408.

Thanabalasingam SJ, Iliescu EA, Norman PA, Day AG, Akbari A, Hundemer GL, et al. Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD. Kidney Med. 2022;4:100440. doi:10.1016/j.xkme.2022.100440

Walker H, Khan S, Padmanabhan S, Pell JP, Lewsey J, Mackay D, et al. Analysis of the kidney failure risk equation implementation in routine clinical practice and health inequalities in chronic kidney disease care: a retrospective cohort study. BMC Nephrol. 2025;26:113. doi:10.1186/s12882-025-04043-0

Ingwiller M, Keller N, Krummel T, Prinz E, Steinmetz L, Hannedouche T, et al. Enhancing vascular access planning in CKD: validating the 40% KFRE threshold for predicting ESKD in a French retrospective cohort study. Clin Kidney J. 2024;17:sfae220. doi:10.1093/ckj/sfae220

O'Hare AM, Bertenthal D, Walter LC, Garg AX, Covinsky K, Kaufman JS, et al. When to refer patients with chronic kidney disease for vascular access surgery: Should age be a consideration? Kidney Int. 2007;71:555–61. doi:10.1038/sj.ki.5002078

da Silva BM, Gameiro J. Generalize the use of the kidney failure risk equation (KFRE) for better vascular access planning. Clin Kidney J. 2024;17:sfae060. doi:10.1093/ckj/sfae060.

Hahn Lundström U, Ramspek CL, Dekker FW, van Diepen M, Carrero JJ, Hedin U, et al. Clinical impact of the Kidney Failure Risk Equation for vascular access planning. Nephrol Dial Transplant. 2024;39:2079-87. doi:10.1093/ndt/gfae064.

Lo R, Narasaki Y, Lei S, Rhee CM. Management of traditional risk factors for the development and progression of chronic kidney disease. Clin Kidney J. 2023;16:1737-50. doi:10.1093/ckj/sfad101.

National Institute for Health and Care Excellence (NICE). Chronic kidney disease: assessment and management (NICE guideline NG203) [accessed Jan 2026] Available at: https://www.nice.org.uk/guidance/ng203

Downloads

Published

13-11-2026

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Issue

Section

Original Article

How to Cite

Validation of the Kidney Failure Risk Equation in a Large Portuguese Cohort: Analysis of Diabetic and Heart Failure Subgroups. (2026). Portuguese Kidney Journal. https://doi.org/10.71749/pkj.140

Similar Articles

31-40 of 96

You may also start an advanced similarity search for this article.